Lannett Receives FDA Approval For Phentermine

Lannett Company, Inc. (Amex:LCI) announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s supplemental Abbreviated New Drug Application (ANDA) of Phentermine Hydrochloride Capsules 30 mg. The company expects to commence marketing this product immediately. Phentermine Hydrochloride (HCl) is indicated for the short-term management of obesity. [click link for full article]

More: continued here

Filed under: Obesity / Weight Loss / Fitness on December 15th, 2007